SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-568434
Filing Date
2016-04-29
Accepted
2016-04-29 14:27:07
Documents
13
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d120192ddefa14a.htm DEFA14A 60155
2 GRAPHIC g120192dsp004a.jpg GRAPHIC 1841
3 GRAPHIC g120192dsp004b.jpg GRAPHIC 34814
4 GRAPHIC g120192dsp004c.jpg GRAPHIC 4975
5 GRAPHIC g120192dsp004d.jpg GRAPHIC 4235
6 GRAPHIC g120192dsp005a.jpg GRAPHIC 1788
7 GRAPHIC g120192dsp005b.jpg GRAPHIC 2327
8 GRAPHIC g120192dsp005c.jpg GRAPHIC 2271
9 GRAPHIC g120192dsp006a.jpg GRAPHIC 1750
10 GRAPHIC g120192dsp006bb.jpg GRAPHIC 7485
11 GRAPHIC g120192dsp006c.jpg GRAPHIC 4394
12 GRAPHIC g120192dsp006d.jpg GRAPHIC 5674
13 GRAPHIC g120192dsp007a.jpg GRAPHIC 1895
  Complete submission text file 0001193125-16-568434.txt   161387
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36281 | Film No.: 161605430
SIC: 2834 Pharmaceutical Preparations